Niraparib in the Treatment of Patients with Advanced PALB2 Mutated Tumors

PHASE2TerminatedINTERVENTIONAL
Enrollment

22

Participants

Timeline

Start Date

March 15, 2022

Primary Completion Date

August 6, 2024

Study Completion Date

August 27, 2024

Conditions
Solid TumorBreast TumorColon Tumor, MalignantLung TumorUrologic CancerPancreatic CancerMelanomaMetastatic CancerLocally Advanced Solid TumorEsophageal CancerEndometrial CancerHead and Neck Cancer
Interventions
DRUG

Niraparib

Eligible participants will receive daily dosing of Niraparib.

Trial Locations (80)

17325

Gettysburg Cancer Center, Gettysburg

20817

The Center for Cancer and Blood Disorders - Maryland, Bethesda

20850

Maryland Oncology Hematology, Rockville

21702

Frederick Health, Frederick

22031

Inova Schar Institute, Fairfax

22408

Hematology Oncology Associates of Fredericksburg, Fredericksburg

23229

Virginia Cancer Institute, Richmond

23230

Virginia Cancer Institute, Richmond

27103

Novant Health Inc. - Winston-Salem, Winston-Salem

27534

Southeastern Medical Oncology Center, Goldsboro

28204

Novant Health Inc. - Charlotte, Charlotte

29607

Bon Secours - St. Francis Cancer Center, Greenville

30607

University Cancer & Blood Center, Athens

32256

Cancer Specialists of North Florida, Jacksonville

33308

Holy Cross, Fort Lauderdale

34474

Ocala Community Cancer Center, Ocala

37232

Vanderbilt University, Nashville

38120

Baptist Cancer Center, Memphis

43214

OhioHealth, Columbus

43623

The Toledo Clinic, Toledo

44106

University Hospitals Seidman, Cleveland

44195

Cleveland Clinic - Taussig Cancer Center, Cleveland

44708

Aultman Medical Group, Canton

45220

TriHealth, Cincinnati

46250

Community Health Network, Indianapolis

46526

Goshen Health, Goshen

46601

Beacon Health System, South Bend

46845

Fort Wayne Medical Oncology and Hematology, Fort Wayne

48912

Sparrow Health, Lansing

53717

SSM Health, Madison

54911

ThedaCare, Appleton

57105

Avera Cancer Institute, Sioux Falls

57117

Sanford Health, Sioux Falls

60008

Northwest Oncology & Hematology, Rolling Meadows

60612

Rush University Medical Center, Chicago

64507

Mosaic Life Care, Saint Joseph

65613

Central Care Cancer Center, Bolivar

65807

Oncology Hematology Associates, Springfield

68130

Nebraska Cancer Specialists, Omaha

70403

Pontchartrain Cancer Center, Hammond

72762

Highlands Oncology, Springdale

74146

Oklahoma Cancer Specialists, Tulsa

75230

Mary Crowley Cancer Research, Dallas

75246

Texas Oncology - Baylor Charles A. Sammons Cancer Center, Dallas

75390

The University of Texas Southwestern Medical Center, Dallas

75460

Texas Oncology - Paris Cancer Center, Paris

75601

Texas Oncology - Longview Cancer Center, Longview

75702

Texas Oncology - Tyler Pharmacy, Tyler

75801

Texas Oncology - Palestine Cancer Center, Palestine

77030

Oncology Consultants, Houston

77479

Lumi Research, Sugar Land

78705

Texas Oncology - Austin Midtown, Austin

78731

Texas Oncology - Austin Central Pharmacy, Austin

78745

Texas Oncology - South Austin, Austin

84106

Utah Cancer Specialists, Salt Lake City

84405

Community Cancer Trials of Utah, Ogden

85364

Yuma Regional Medical Center, Yuma

89102

OptumCare Cancer Care, Las Vegas

90404

University of California Los Angeles, Los Angeles

90720

Cancer and Blood Specialty Clinic, Los Alamitos

Cancer and Blood Specialty, Los Alamitos

90806

MemorialCare, Long Beach

92123

Sharp Healthcare, San Diego

92708

Memorial Care Medical Center, Fountain Valley

92835

St Joseph Heritage Health - Fullerton, Fullerton

93030

Ventura County Hematology Oncology Specialists, Oxnard

93105

Ridley-Tree Cancer Center, Santa Barbara

94558

St Joseph Health Medical Group - Napa, Napa

95403

St Joseph Health Medical Group - Santa Rosa, Santa Rosa

96813

Hawaii Cancer Care, Honolulu

97301

Oregon Oncology Specialists, Salem

98225

PeaceHealth, Bellingham

98405

Northwest Medical Specialties, Tacoma

92093-0698

University of California San Diego, La Jolla

06102

Hartford Healthcare, Hartford

06360

Eastern Connecticut Hematology and Oncology, Norwich

02719

Southcoast Health, Fairhaven

07109

New Jersey Cancer Care and Blood Disorders, Belleville

07631

Englewood Health, Englewood

07932

Summit Medical Group, Florham Park

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

GlaxoSmithKline

INDUSTRY

lead

Tempus AI

INDUSTRY

NCT05169437 - Niraparib in the Treatment of Patients with Advanced PALB2 Mutated Tumors | Biotech Hunter | Biotech Hunter